These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 8767536

  • 1. Whole megakaryocytes are present among CD34+ cells in the peripheral blood of patients with acute myeloid leukemia after intensive chemotherapy.
    Delfini C, Centis F, Annibali M.
    Haematologica; 1996; 81(3):284-5. PubMed ID: 8767536
    [No Abstract] [Full Text] [Related]

  • 2. Correlation between CD34 expression and chromosomal abnormalities but not clinical outcome in acute myeloid leukemia.
    Fruchart C, Lenormand B, Bastard C, Boulet D, Lesesve JF, Callat MP, Stamatoullas A, Monconduit M, Tilly H.
    Am J Hematol; 1996 Nov; 53(3):175-80. PubMed ID: 8895688
    [Abstract] [Full Text] [Related]

  • 3. Peripheral blood stem cells mobilized from patients with acute myeloid leukaemia have different platelet repopulating abilities compared with those mobilized from patients with other diseases.
    Roberts MM, Dyson PG, Willson K, Juttner CA, To LB.
    Bone Marrow Transplant; 1996 Jul; 18(1):41-5. PubMed ID: 8831994
    [Abstract] [Full Text] [Related]

  • 4. Ajoene, a garlic-derived natural compound, enhances chemotherapy-induced apoptosis in human myeloid leukaemia CD34-positive resistant cells.
    Ahmed N, Laverick L, Sammons J, Zhang H, Maslin DJ, Hassan HT.
    Anticancer Res; 2001 Jul; 21(5):3519-23. PubMed ID: 11848518
    [Abstract] [Full Text] [Related]

  • 5. Standard induction chemotherapy followed by attenuated consolidation in elderly patients with acute myeloid leukemia.
    Lee JH, Choi SJ, Lee JH, Park JH, Kim H, Joo YD, Lee WS, Zang DY, Kim HJ, Lee KH, Cooperative Study Group A for Hematology.
    Ann Hematol; 2006 Jun; 85(6):357-65. PubMed ID: 16575580
    [Abstract] [Full Text] [Related]

  • 6. [Acute leukemia: which of two types of cell death (necrosis or apoptosis) may be responsible for patients' death during intensive chemotherapy?].
    Petukhov VI, Pavlov BN.
    Ter Arkh; 2002 Jun; 74(12):100-4. PubMed ID: 12577856
    [No Abstract] [Full Text] [Related]

  • 7. Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities.
    Costello RT, Mallet F, Gaugler B, Sainty D, Arnoulet C, Gastaut JA, Olive D.
    Cancer Res; 2000 Aug 15; 60(16):4403-11. PubMed ID: 10969785
    [Abstract] [Full Text] [Related]

  • 8. How high can we increase complete remission rate in adult acute myeloid leukemia?
    Ohno R.
    Int J Hematol; 2000 Oct 15; 72(3):272-9. PubMed ID: 11185981
    [Abstract] [Full Text] [Related]

  • 9. Assessment of distribution of CD34 epitope classes in fresh and cryopreserved peripheral blood progenitor cells and acute myeloid leukemic blasts.
    Lanza F, Moretti S, Castagnari B, Montanelli F, Latorraca A, Ferrari L, Bardi A, Dominici M, Campioni D, Dabusti M, Piva N, Lodi G, Reverberi R, Castoldi G.
    Haematologica; 1999 Nov 15; 84(11):969-77. PubMed ID: 10553156
    [Abstract] [Full Text] [Related]

  • 10. [Poor response in patients with de novo acute myeloid leukemia and erythroblastic or megakaryocytic dysplasia to treatment with standard doses of cytosine arabinoside and daunorubicin].
    Lemez P, Gáliková J, Haas T.
    Vnitr Lek; 1999 Jun 15; 45(6):342-6. PubMed ID: 11045169
    [Abstract] [Full Text] [Related]

  • 11. High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival.
    van Rhenen A, Feller N, Kelder A, Westra AH, Rombouts E, Zweegman S, van der Pol MA, Waisfisz Q, Ossenkoppele GJ, Schuurhuis GJ.
    Clin Cancer Res; 2005 Sep 15; 11(18):6520-7. PubMed ID: 16166428
    [Abstract] [Full Text] [Related]

  • 12. Differences in anti-apoptotic and multidrug resistance phenotypes in elderly and young acute myeloid leukemia patients are related to the maturation of blast cells.
    Suárez L, Vidriales MB, Moreno MJ, López A, García-Laraña J, Pérez-López C, Tormo M, Lavilla E, López-Berges MC, de Santiago M, San Miguel JF, Orfao A, PETHEMA Cooperative Group.
    Haematologica; 2005 Jan 15; 90(1):54-9. PubMed ID: 15642669
    [Abstract] [Full Text] [Related]

  • 13. [Effect of treatment of leukemia on blast transformation of leukemia cells in vitro].
    Kiersnowska-Rogowska B, Rogowski F, Giedrojć J, Bielawiec M.
    Pol Tyg Lek; 1987 Aug 17; 42(33):1005-7. PubMed ID: 3480508
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Multivariate analyses of prognostic factors in acute myeloid leukemia: relevance of cytogenetic abnormalities and CD34 expression.
    Junghanss C, Waak M, Knopp A, Kleine HD, Kundt G, Leithäuser M, Hilgendorf I, Wolff D, Casper J, Freund M.
    Neoplasma; 2005 Aug 17; 52(5):402-10. PubMed ID: 16151585
    [Abstract] [Full Text] [Related]

  • 17. Therapy for elderly patients with acute myeloid leukemia: a problem in search of solutions.
    Kantarjian HM.
    Cancer; 2007 Mar 15; 109(6):1007-10. PubMed ID: 17279580
    [No Abstract] [Full Text] [Related]

  • 18. Optimal post-remission therapy for flow-cytometry minimal residual disease positive adult patients with acute myeloid leukemia.
    Buccisano F, Maurillo L, Del Poeta G, Gattei V, Amadori S, Venditti A.
    Haematologica; 2006 Dec 15; 91(12 Suppl):ELT14; author reply ELT15. PubMed ID: 17194674
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.